Correspondence
- PMID: 37536663
- DOI: 10.1097/IAE.0000000000003903
Correspondence
References
-
- Spaide RF, Vavvas DG. Complement inhibition for geographic atrophy: review of salient functional outcomes and perspective. Retina 2023;43:1064–1069.
-
- Liao DS, Grossi FV, El Mehdi D, et al. Complement C3 inhibitor pegcetacoplan for geographic atrophy secondary to age-related macular degeneration: a randomized phase 2 trial. Ophthalmology 2020;127:186–195.
-
- Available at: https://clinicaltrials.gov/ct2/show/NCT02503332 . Accessed September 2023.
-
- Yehoshua Z, de Amorim Garcia Filho CA, Nunes RP, et al. Systemic complement inhibition with eculizumab for geographic atrophy in age-related macular degeneration: the COMPLETE study. Ophthalmology 2014;121:693–701.
-
- Heier JS, Pieramici D, Chakravarthy U, et al. Visual function decline resulting from geographic atrophy: results from the chroma and Spectri phase 3 trials. Ophthalmol Retina 2020;4:673–688.
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources